Page last updated: 2024-11-05

trifluoperazine and Porphyrias

trifluoperazine has been researched along with Porphyrias in 2 studies

Porphyrias: A diverse group of metabolic diseases characterized by errors in the biosynthetic pathway of HEME in the LIVER, the BONE MARROW, or both. They are classified by the deficiency of specific enzymes, the tissue site of enzyme defect, or the clinical features that include neurological (acute) or cutaneous (skin lesions). Porphyrias can be hereditary or acquired as a result of toxicity to the hepatic or erythropoietic marrow tissues.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
LEE, DF1
LUCAS, GJ1
Gibney, GN1
Jones, IH1
Meek, JH1

Other Studies

2 other studies available for trifluoperazine and Porphyrias

ArticleYear
Acute intermittent porphyria treated with trifluoperazine.
    United States Armed Forces medical journal, 1959, Volume: 10

    Topics: Animals; Humans; Porifera; Porphyria, Acute Intermittent; Porphyrias; Tranquilizing Agents; Trifluop

1959
Schizophrenia in association with erythropoietic protoporphyria--report of a case.
    The British journal of psychiatry : the journal of mental science, 1972, Volume: 121, Issue:560

    Topics: Adolescent; Aggression; Delusions; Depression; Erythropoiesis; Humans; Interpersonal Relations; Male

1972